AI-Driven Cancer Drug Discovery Archives

Technology & Infrastructure · Models & LLMs

Rakovina Therapeutics Strengthens AI-Driven Cancer Drug Discovery Partnership with Variational AI

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company pioneering DNA-damage response therapies, has reaffirmed its strategic partnership with Variational AI. The announcement follows Variational AI’s successful $5.5 million oversubscribed financing round, led

3 Mar 2025 · 2 min read

AI-Driven Cancer Drug Discovery

Rakovina Therapeutics Strengthens AI-Driven Cancer Drug Discovery Partnership with Variational AI

Trending today

Anthropic’s Claude Designs More Efficient Quantum Circuits With Automated Feedback

Zap Surgical Raises $36M in Funding to Scale Non-Invasive Robotic Brain Surgery

AWS Takes Aim at Nvidia’s PyTorch Advantage While Nvidia Expands Open-Weight Nemotron Models for Agents

Otter.ai Raises $320M From General Catalyst’s Customer Value Fund to Expand Enterprise AI

Inovia Capital Secures $200M First Close for AI-Focused Sixth Venture Fund

AI-Driven Cancer Drug Discovery

Rakovina Therapeutics Strengthens AI-Driven Cancer Drug Discovery Partnership with Variational AI

Trending today

Anthropic’s Claude Designs More Efficient Quantum Circuits With Automated Feedback

Zap Surgical Raises $36M in Funding to Scale Non-Invasive Robotic Brain Surgery

AWS Takes Aim at Nvidia’s PyTorch Advantage While Nvidia Expands Open-Weight Nemotron Models for Agents

Otter.ai Raises $320M From General Catalyst’s Customer Value Fund to Expand Enterprise AI

Inovia Capital Secures $200M First Close for AI-Focused Sixth Venture Fund

The AI economy, every weekday morning